Outcomes between DVT-only and AF cohorts
After propensity matching, there was no substantial difference in the baseline characteristics between the DVT-only and AF cohorts (Supplemental table 1). Clinical outcomes between DVT-only and AF cohorts are shown in Supplemental table 6.
The incidence of arterial thromboembolic event was lower in the DVT-only cohort than that in the AF cohort (SHR, 0.62; 95% CI, 0.59–0.65) (Figure 3A). The risks of ischemic stroke (SHR, 0.45; 95% CI, 0.43–0.48) (Figure 3B) and MI (SHR, 0.76; 95% CI, 0.67–0.86) were lower, while the risk of ECATE was higher, in the DVT-only cohort (SHR, 1.31; 95% CI, 1.20–1.43) (Figure 3C). All-cause mortality rates were higher in the DVT-only cohort (HR, 1.14; 95% CI, 1.11–1.17), while the rate of CV death was lower (HR, 0.89; 95% CI, 0.85–0.92) (Figure 3D and Figure 3E).